Skip to main content
. Author manuscript; available in PMC: 2017 Oct 15.
Published in final edited form as: Int J Cardiol. 2016 Jul 9;221:789–793. doi: 10.1016/j.ijcard.2016.07.119

Table 1.

Data on subjects aged 45+ years (n=11,699) with a diagnosis of atrial fibrillation and without (n=10,699) or with (n=1000) myocardial infarction (MI) after AF diagnosis in primary care from 1 January 2001 to 31 December 2007

Women Men
Without MI With MI Without MI With MI
n=4,926 n=472 p-value n=5,773 n=528 p-value
Age (years), mean (SD) 76.8 (9.4) 79.8 (8.0) <0.001 71.7 (10.3) 75.6 (8.8) <0.001
Age group (years) <0.001 <0.001
 45–54 101 (2.1) 1 (0.2) 352 (6.1) 14 (2.7)
 55–64 484 (9.8) 23 (4.9) 1,119 (19.4) 55 (10.4)
 65–74 1,144 (23.2) 75 (15.9) 1,795 (31.1) 132 (25.0)
 75–84 2,176 (44.2) 246 (52.2) 1,943 (33.7) 261 (49.4)
 85+ 1,021 (20.7) 127 (26.9) 564 (9.8) 66 (12.5)
Neighborhood SES 0.043 0.016
 High 1,729 (35.1) 146 (30.9) 2,330 (40.4) 200 (37.9)
 Middle 2,420 (49.1) 233 (49.4) 2,646 (45.8) 231 (43.8)
 Low 777 (15.8) 93 (19.7) 797 (13.8) 97 (18.4)
Marital status 0.002 <0.001
 Married 1,485 (30.3) 115 (24.5) 3,443 (59.9) 298 (56.7)
 Unmarried 361 (7.4) 26 (5.5) 561 (9.8) 40 (7.6)
 Divorced 695 (14.2) 60 (12.8) 903 (15.7) 74 (14.1)
 Widowed 2,362 (48.2) 268 (57.1) 844 (14.7) 114 (21.7)
Educational level <0.001 <0.001
 Compulsory school 2,240 (51.5) 236 (59.8) 2,114 (38.6) 238 (48.2)
 Secondary school 1,442 (33.2) 126 (31.9) 2,068 (37.8) 173 (35.0)
 College/university 665 (15.3) 33 (8.3) 1,292 (23.6) 83 (16.8)
AF-related disease
 Hypertension 2,394 (48.6) 239 (50.6) 0.40 2,377 (41.2) 236 (44.7) 0.12
 CHD 801 (16.3) 210 (44.5) <0.001 849 (14.7) 255 (48.3) <0.001
 Heart failure 974 (19.8) 116 (24.6) 0.013 933 (16.2) 133 (25.2) <0.001
 Valvular disease 232 (4.7) 33 (7.0) 0.028 254 (4.4) 25 (4.7) 0.72
 Cardiomyopathy 27 (0.6) 1 (0.2) 0.51 53 (0.9) 5 (1.0) 0.95
 CVS 582 (11.8) 48 (10.2) 0.29 638 (111) 49 (9.3) 0.22
 Diabetes mellitus 914 (18.6) 120 (25.4) 0.001 1,072 (18.6) 134 (25.4) 0.001
Drugs
 Ever warfarin 2,381 (48.3) 187 (39.6) <0.001 3,227 (55.9) 272 (51.5) 0.052
 Warfarin ITT 2,296 (46.6) 158 (33.5) <0.001 3,118 (54.0) 241 (45.6) <0.001
 Warfarin PP 1,679 (34.1) 67 (14.2) <0.001 2,229 (38.6) 97 (18.4) <0.001
 Ever ASA 2,786 (56.6) 330 (69.9) <0.001 2,910 (50.4) 352 (66.7) <0.001
 ASA ITT 2,461 (50.0) 296 (62.7) <0.001 2,584 (44.8) 299 (56.6) <0.001
 ASA PP 1,479 (30.0) 125 (26.5) 0.11 1,614 (28.0) 124 (23.5) 0.028
 Ever clopidogrel 122 (2.5) 40 (8.5) <0.001 111 (1.9) 59 (11.2) <0.001
 Clopidogrel ITT 89 (1.8) 8 (1.7) 0.58 91 (1.6) 10 (1.9) 0.86
 Clopidogrel PP 38 (0.8) 4 (0.9) 0.78 34 (0.6) 6 (1.1) 0.13

Prescription of warfarin was classified as “intention-to-treat” (“ITT”) if ever present before the years of MI, or present among subjects without MI. Prescription of warfarin was classified as “per-protocol” (“PP”) if present the year before and the year of first MI, or present among subjects without MI if present during at least three years, at least 50% of actual years after first recorded year of AF, or during both 2006 and 2007.